Cargando…

Improvement in insulin sensitivity following intensive insulin therapy and association of glucagon with long-term diabetes remission

OBJECTIVE: To investigate the role of the acute glucagon response in the long-term remission of newly diagnosed type 2 diabetes mellitus following short-term intensive insulin therapy (IIT). METHODS: Ten patients with newly diagnosed type 2 diabetes mellitus received IIT. Intravenous glucose toleran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Bo, Chen, Yan-yan, Yang, Zhao-jun, Wang, Xin, Li, Guang-wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2016
Materias:	Clinical Notes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536741/ https://www.ncbi.nlm.nih.gov/pubmed/27834301 http://dx.doi.org/10.1177/0300060516668433

Ejemplares similares

Short-Term Intensive Therapy in Newly Diagnosed Type 2 Diabetes Partially Restores Both Insulin Sensitivity and β-Cell Function in Subjects With Long-Term Remission
por: Hu, Yun, et al.
Publicado: (2011)

Impaired glucagon suppression and reduced insulin sensitivity in subjects with prediabetes undergoing atorvastatin therapy
por: Urbano, Francesca, et al.
Publicado: (2019)

Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction
por: Karwi, Qutuba G., et al.
Publicado: (2019)

Insulin and Glucagon: Partners for Life
por: Holst, Jens Juul, et al.
Publicado: (2017)

Insulin and Glucagon Impairments in Relation with Islet Cells Morphological Modifications Following Long Term Pancreatic Duct Ligation in the Rabbit – A Model of Non-insulin-dependent Diabete
por: Catala, J., et al.
Publicado: (2001)

Hypoglycemia during Short-Term Intensive Insulin Therapy and Its Association with Long-Term Glycemic Remission in Patients with Newly Diagnosed Type 2 Diabetes
por: Xu, Lijuan, et al.
Publicado: (2020)

Predictors of sustained drug-free diabetes remission over 48 weeks following short-term intensive insulin therapy in early type 2 diabetes
por: Kramer, Caroline K, et al.
Publicado: (2016)

The relationship between insulin and glucagon concentrations in non‐diabetic humans
por: Laurenti, Marcello C., et al.
Publicado: (2022)

FGF21 regulates insulin sensitivity following long-term chronic stress
por: Jelenik, Tomas, et al.
Publicado: (2018)

Dual treatment with a fixed ratio of glucagon and insulin increases the therapeutic window of insulin in diabetic rats
por: Pedersen, Christina, et al.
Publicado: (2018)

High Protein Diets Improve Liver Fat and Insulin Sensitivity by Prandial but Not Fasting Glucagon Secretion in Type 2 Diabetes
por: Zhang, Jiudan, et al.
Publicado: (2022)

Gynostemma pentaphyllum Tea Improves Insulin Sensitivity in Type 2 Diabetic Patients
por: Huyen, V. T. T., et al.
Publicado: (2013)

Effect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis
por: Tiano, Joseph P., et al.
Publicado: (2015)

Effects of Sitagliptin on Insulin and Glucagon Levels in Type 2 Diabetes Mellitus
por: Kim, Ji Hyun
Publicado: (2015)

Long-Term Follow-Up of Oral Glucose Tolerance Test–Derived Glucose Tolerance and Insulin Secretion and Insulin Sensitivity Indexes in Subjects With Glucokinase Mutations (MODY2)
por: Martin, Delphine, et al.
Publicado: (2008)

Insulin Reciprocally Regulates Glucagon Secretion in Humans
por: Cooperberg, Benjamin A., et al.
Publicado: (2010)

Insulin and Glucagon Regulate Pancreatic α-Cell Proliferation
por: Liu, Zhuo, et al.
Publicado: (2011)

Microsatellite and Single Nucleotide Polymorphisms in the Insulin-Like Growth Factor 1 Promoter with Insulin Sensitivity and Insulin Secretion
por: Wang, Ruyao, et al.
Publicado: (2017)

Measures of insulin sensitivity, leptin, and adiponectin concentrations in cats in diabetic remission compared to healthy control cats
por: Gottlieb, Susan, et al.
Publicado: (2022)

Temporal Patterns of Glucagon and Its Relationships with Glucose and Insulin following Ingestion of Different Classes of Macronutrients
por: Göbl, Christian, et al.
Publicado: (2022)

Insulin, Insulin Resistance, and Platelet Signaling in Diabetes
por: Randriamboavonjy, Voahanginirina, et al.
Publicado: (2009)

Insulin Receptor Trafficking: Consequences for Insulin Sensitivity and Diabetes
por: Chen, Yang, et al.
Publicado: (2019)

Glucagon Receptor Knockout Prevents Insulin-Deficient Type 1 Diabetes in Mice
por: Lee, Young, et al.
Publicado: (2011)

Association of Glucagon to Insulin Ratio and Metabolic Syndrome in Patients with Type 2 Diabetes
por: Bang, Jisun, et al.
Publicado: (2023)

Adiponectin levels and its relation with insulin secretion and insulin sensitivity in a group of sub-Saharan African women with polycystic ovary syndrome
por: Momo, Audrey Synthia, et al.
Publicado: (2022)

Characteristics and Determinants of Partial Remission in Children with Type 1 Diabetes Using the Insulin-Dose-Adjusted A1C Definition
por: Pecheur, Aurore, et al.
Publicado: (2014)

The Insulin:Glucagon Ratio and the Choice of Glucose-Lowering Drugs
por: Kalra, Sanjay, et al.
Publicado: (2016)

Acute Glucagon Induces Postprandial Peripheral Insulin Resistance
por: Patarrão, Rita S., et al.
Publicado: (2015)

Mathematical Model of Glucagon Kinetics for the Assessment of Insulin-Mediated Glucagon Inhibition During an Oral Glucose Tolerance Test
por: Morettini, Micaela, et al.
Publicado: (2021)

Long‐term efficacy and safety of combined insulin and glucagon‐like peptide‐1 therapy: Evidence from the LEADER trial
por: Tack, Cees J., et al.
Publicado: (2019)

Editorial: Non-insulin hypoglycemic drugs in type 2 diabetes remission
por: Guo, Kai-heng, et al.
Publicado: (2023)

Glucagon-Like Peptide 1 Recruits Muscle Microvasculature and Improves Insulin’s Metabolic Action in the Presence of Insulin Resistance
por: Chai, Weidong, et al.
Publicado: (2014)

Comparison of a Multiple Daily Insulin Injection Regimen (Glargine or Detemir Once Daily Plus Prandial Insulin Aspart) and Continuous Subcutaneous Insulin Infusion (Aspart) in Short-Term Intensive Insulin Therapy for Poorly Controlled Type 2 Diabetes Patients
por: Lv, Wen-shan, et al.
Publicado: (2013)

Partial Clinical Remission of Type 1 Diabetes: The Need for an Integrated Functional Definition Based on Insulin-Dose Adjusted A1c and Insulin Sensitivity Score
por: Nwosu, Benjamin Udoka
Publicado: (2022)

Lower mean blood glucose during short‐term intensive insulin therapy is associated with long‐term glycemic remission in patients with newly diagnosed type 2 diabetes: Evidence‐based recommendations for standardization
por: Liu, Liehua, et al.
Publicado: (2017)

Operational Definitions of Treatment Response and Remission in Obsessive-Compulsive Disorder Capture Meaningful Improvements in Everyday Life
por: Mataix-Cols, David, et al.
Publicado: (2022)

Effects of liraglutide on postprandial insulin and glucagon responses in Japanese patients with type 2 diabetes
por: Matsumoto, Shinobu, et al.
Publicado: (2013)

Optimal regulation of blood glucose level in Type I diabetes using insulin and glucagon
por: Shirin, Afroza, et al.
Publicado: (2019)

Current perspective on the role of insulin and glucagon in the pathogenesis and treatment of type 2 diabetes mellitus
por: Ojha, Ashutosh, et al.
Publicado: (2019)

Brain Glucagon-Like Peptide-1 Regulates Arterial Blood Flow, Heart Rate, and Insulin Sensitivity
por: Cabou, Cendrine, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_cgis1op0i6kprl6jamatmu9qhv